Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification?A prospective placebo-controlled study using low-dose sotalol
Author(s) -
Uta Klöter Weber,
Sandra Osswald,
Maurus Huber,
P Buser,
K. Skarvan,
P Stulz,
Christian Schmidhauser,
M Pfisterer
Publication year - 1998
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1053/euhj.1997.0838
Subject(s) - medicine , sotalol , atrial fibrillation , discontinuation , cardiology , prospective cohort study , cardiac surgery , incidence (geometry) , randomized controlled trial , anesthesia , antiarrhythmic agent , placebo , heart disease , physics , alternative medicine , pathology , optics
This study evaluated the advantages of 'selective' over 'non-selective' antiarrhythmic prevention of atrial fibrillation after coronary surgery based on a new risk prediction algorithm.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom